ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership

This study is currently recruiting participants.
Verified by Emory University, June 2006

Sponsors and Collaborators: Emory University
National Institutes of Health (NIH)
Morehouse School of Medicine
Information provided by: Emory University
ClinicalTrials.gov Identifier: NCT00336869
  Purpose

The theme of this Morehouse-Emory Partnership Program focuses on elucidating the etiologic basis of ethnic differences in obesity-related CVD and discovering new intervention strategies to ameliorate CV health in all communities. The proposed Program uses a multi-disciplinary strategy to systematically characterize ethnic differences in obesity-related CVD by drawing upon the fields of physiology, psychology, biochemistry, vascular biology, public health, nursing and clinical medicine.


Condition Phase
Metabolic Symdrome
Phase II

U.S. FDA Resources

Study Type:   Observational
Study Design:   Cross-Sectional, Random Sample, Retrospective/Prospective Study

Further study details as provided by Emory University:

Study Start Date:   December 2005

Detailed Description:

Emerging evidence indicates that there are ethnicity-specific differences in the profile of biochemical, metabolic and physiological perturbations associated with obesity. The implications of these ethnic differences remain to be further defined. Several epidemiologic studies have shown that vascular disease and its cardiovascular complications, carry significantly higher morbidity and mortality in African Americans compared with Caucasians.1-3 These observations may be partly explained by a higher prevalence of cardiovascular disease risk factors, such as essential hypertension, diabetes mellitus, and tobacco use among African Americans.4-6 However, the pathophysiological processes underlying this racial predisposition have not been fully elucidated.7 It is likely that the etiologic basis of ethnic disparities in cardiovascular disease is multi-factorial and involves dynamic gene-environment interactions in which variances in behavior and the social context are critical determinants.

The proposed Program recognizes the importance of incorporating both biological factors and social determinants in the analysis of cardiovascular disparities

  Eligibility
Ages Eligible for Study:   30 Years to 65 Years
Genders Eligible for Study:   Both

Criteria

Inclusion Criteria:

Our methodological approach will involve a random digit-dialing cross-sectional survey of 4000 Metro Atlanta area AA and white residents (ages 30-65 years). This aim will focus on using well-validated survey instruments to examine self-reported perceptions of psychosocial stress, neighborhood segregation factors and health beliefs related to weight/weight control. These parameters will be assessed in relation to the differential prevalence of three major outcomes: (1) self-reported maladaptive cardiovascular behaviors that predispose to obesity-related CVD (ie high fat/sodium and low fruit/vegetables dietary intake and physical inactivity); (2) obesity; and (3) hypertension.

This study will address the following research questions: Are the observed racial differences in maladaptive health behaviors (diet/inactivity) and MetS components (obesity, hypertension) associated with: a) perceived psychosocial stress, and if so, does depression, neighborhood factors or health beliefs around weight and weight control modify this relationship?

-

Exclusion Criteria:

-

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00336869

Locations
United States, Georgia
Emory GCRC     Recruiting
      Atlanta, Georgia, United States, 30329
      Contact: Yusuf Ahmed, MD, MPH     404-712-9194     yahmed@emory.edu    
      Contact: Tara Rogers, Bs     (404) 756-8820     trogers@msm.edu    
Morehouse CRC     Recruiting
      Atlanta, Georgia, United States, 30310
      Contact: Marie Vero-Bielo, MD, MPH     404-752-1070        
      Contact: Neli Stoyanova, MD,Ms     (404) 756-5043        
      Principal Investigator: Rebecca Din, MD, MPH, PHD            

Sponsors and Collaborators
Emory University
National Institutes of Health (NIH)
Morehouse School of Medicine

Investigators
Principal Investigator:     Arshed Quyyumi, MD     Emory University    
Principal Investigator:     Gary Gibbons, MD     Morehouse School of Medicine    
  More Information


Study ID Numbers:   1024-2004
First Received:   June 12, 2006
Last Updated:   June 12, 2006
ClinicalTrials.gov Identifier:   NCT00336869
Health Authority:   United States: Federal Government

ClinicalTrials.gov processed this record on September 25, 2008




Links to all studies - primarily for crawlers